Language
Your Language
Fucithalmic®

Look again at how you treat bacterial conjunctivitis or blepharitis.

Patient Choice

According to global market research conducted in five countries in 278 patients, Fucithalmic® was preferred by 62% of patients compared with tobramycin, 66% of patients preferred Fucithalmic® over chloramphenicol and 85% preferred Fucithalmic®compared with moxifloxacin.1

Fucithalmic Graphs English 05

Figure 5. The same market research across age groups indicates that ‘dosage’ is the most important product feature when considering bacterial conjunctivitis treatment.1

REFERENCES:

  1. Global Market Research conducted on bacterial conjunctivitis in 5 countries in 278 patients (Concordia Rx - Fucithalmic® . Bacterial Conjunctivitis: Patient Market Research - Data on File. June 2018)